These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3159218)

  • 1. Aspirin and dipyridamole reduce lipid accumulation in vein bypass grafts: combination versus single drug therapy.
    Boerboom LE; Olinger GN; Bonchek LI; Kissebah AH
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():315-7. PubMed ID: 3159218
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose aspirin protects against lipid accumulation in primate vein bypass grafts.
    Boerboom LE; Olinger GN; Kissebah AH; Montgomery RR
    J Thorac Cardiovasc Surg; 1987 Aug; 94(2):251-5. PubMed ID: 3613624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin or dipyridamole individually prevent lipid accumulation in primate vein bypass grafts.
    Boerboom LE; Olinger GN; Bonchek LI; Gunay II; Kissebah AH
    Am J Cardiol; 1985 Feb; 55(5):556-9. PubMed ID: 3969898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulation].
    Pfisterer M; Jockers G; Burkart F; Schmitt HE; Wolff G; Skarvan K; Stulz P; Hasse J; Grädel E
    Schweiz Med Wochenschr; 1987 Oct; 117(43):1688-92. PubMed ID: 3501162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug trials in prevention of occlusion of aorta--coronary artery vein grafts.
    Chesebro JH; Fuster V
    J Thorac Cardiovasc Surg; 1982 Jan; 83(1):90-3. PubMed ID: 7033674
    [No Abstract]   [Full Text] [Related]  

  • 6. Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial.
    Rajah SM; Salter MC; Donaldson DR; Subba Rao R; Boyle RM; Partridge JB; Watson DA
    J Thorac Cardiovasc Surg; 1985 Sep; 90(3):373-7. PubMed ID: 3897722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of intimal thickening in canine coronary bypass vein grafts with dipyridamole and aspirin.
    Metke MP; Lie JT; Fuster V; Josa M; Kaye MP
    Am J Cardiol; 1979 Jun; 43(6):1144-8. PubMed ID: 312596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet and anticoagulant therapy after coronary bypass.
    Phillips SJ; Kongtahworn C; Zeff RH; Beshany SE
    N Engl J Med; 1980 Apr; 302(15):866. PubMed ID: 6965762
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
    Sharma GV; Khuri SF; Josa M; Folland ED; Parisi AF
    Circulation; 1983 Sep; 68(3 Pt 2):II218-21. PubMed ID: 6347428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulants].
    Loeliger EA
    Schweiz Med Wochenschr; 1988 Mar; 118(12):447-9. PubMed ID: 3259724
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of dipyridamole in addition to low dose aspirin in the prevention of occlusion of coronary artery bypass grafts.
    Agnew TM; French JK; Neutze JM; Whitlock RM; Brandt PW; Kerr AR; Webber BJ; Rutherford JD
    Aust N Z J Med; 1992 Dec; 22(6):665-70. PubMed ID: 1489290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipyridamole and aspirin and patency of coronary bypass grafts.
    von Schacky C
    N Engl J Med; 1984 Jun; 310(23):1533-4. PubMed ID: 6609308
    [No Abstract]   [Full Text] [Related]  

  • 13. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
    Houben JJ; Nicolai G
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2225; author reply 2225-6. PubMed ID: 8247173
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspirin-dipyridamole prophylaxis of sickle cell disease pain crises.
    Chaplin H; Alkjaersig N; Fletcher AP; Michael JM; Joist JH
    Thromb Haemost; 1980 Jul; 43(3):218-21. PubMed ID: 7006142
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of dipyridamole in the therapy of vascular disease.
    Green D; Miller V
    Geriatrics; 1993 Jan; 48(1):46, 51-3, 57-8. PubMed ID: 8419269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)].
    Bousser MG; Eschwege E; Haguenau M; Lefauconnier JM; Touboul D; Touboul PJ
    Rev Neurol (Paris); 1981; 137(5):333-41. PubMed ID: 7027408
    [No Abstract]   [Full Text] [Related]  

  • 17. [Secondary prevention after stroke. Doubled performs better].
    MMW Fortschr Med; 2003 Nov; 145(46):49. PubMed ID: 14699837
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduction of thrombosis in canine coronary bypass vein grafts with dipyridamole and aspirin.
    Josa M; Lie JT; Bianco RL; Kaye MP
    Am J Cardiol; 1981 Jun; 47(6):1248-54. PubMed ID: 6972158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the effects of aspirin and dipyridamole on platelet function and prevention of intimal hyperplasia in autologous vein grafts.
    Landymore RW; Karmazyn M; MacAulay MA; Sheridan B; Cameron CA
    Can J Cardiol; 1988; 4(1):56-9. PubMed ID: 3359354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the interaction of warfarin with aspirin and dipyridamole.
    Donaldson DR; Sreeharan N; Crow MJ; Rajah SM
    Thromb Haemost; 1982 Feb; 47(1):77. PubMed ID: 6978549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.